Abstract

Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2023 - Volume 27, Number 1

Page(s): 30-37

Download in electronic PDF format for $75
  • Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Page 1
  • Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Page 2
  • Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Page 3
  • Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Page 4
  • Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Page 5
  • Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Page 6
  • Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Page 7
  • Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Page 8

Abstract

Microneedle arrays, or microneedle array patches (terms are often used interchangeably), are promising devices for the transdermal delivery of drugs and vaccines. Unique microneedle arrays can be prepared from various materials and can be either solid or hollow. Upon insertion, they rapidly take up skin interstitial fluid to form continuous, open conduits from the attached patch-type drug reservoirs to the dermal microcirculation. Microneedle array patches can be prepared using molds in a wide range of patch sizes and microneedle geometries, can be easily sterilized, resist hole closure while in place, and are removed completely intact from the skin. Delivery of macromolecules is no longer limited to what can be loaded into the microneedles themselves, as they can also be loaded as a reservoir and delivered through the microneedles. Also, transdermal drug delivery can now be controlled by the cross-linked density of the hydrogel matrix rather than the stratum corneum. This newer technology has the potential to overcome limitations of conventional microneedle designs and to greatly increase the range of the type of drug that is deliverable transdermally, which benefits industry, healthcare providers, and, ultimately, patients.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2023
Pg. 30-37
Author(s): Allen Loyd V Jr
Nov/Dec 2022
Pg. 490-495
Author(s): Allen Loyd V Jr
Sep/Oct 2022
Pg. 400-408
Author(s): Allen Loyd V Jr
Mar/Apr 2003
Pg. 106-113
Author(s): Davidson Gigi S
May/Jun 2004
Pg. 181-185
Sep/Oct 2022
Pg. 356
Author(s): Allen Loyd V Jr
Jan/Feb 2012
Pg. 62-63
Jul/Aug 2004
Pg. 269-274
Mar/Apr 2015
Pg. 152-160
Nov/Dec 2015
Pg. 491-500
Author(s): Akers Michael J
Nov/Dec 2015
Pg. 453-463
Author(s): Timko Robert J
Jan/Feb 2019
Pg. 65-69
Jan/Feb 2020
Pg. 30-36
Author(s): Dillon L R
Mar/Apr 2015
Pg. 121-124
Author(s): Akers Michael J
Jul/Aug 2005
Pg. 300-302
Jul/Aug 2006
Pg. 281-284
Author(s): Zolner William J
Jan/Feb 2014
Pg. 6-12
Sep/Oct 2009
Pg. 412-418
Author(s): Zolner William J
May/Jun 2015
Pg. 215-221
Author(s): Akers Michael J
Sep/Oct 2014
Pg. 366-369